Videos

Rebecca Leach, RN, BSN, MPH, CIC: “Infection preventionists had to work very closely with our supply chain and look at all of our options and really keep track of it. I also think working with lab more closely will be important in the future, to understand testing modalities, understanding our abilities to test and interpreting those tests.”

Deborah Chung: “With the 40% of healthcare workers wanting better hand hygiene training pre-COVID, I can only assume that’s been exponentially surged.”

Kevin Kavangh, MD: “What worries me the most about reopening is that people going to say, ‘Oh, it’s over with’ and not do any sort of protection, whether it’s social distancing, wearing masks, not gathering in crowds. I really think that people will think, ‘Well, we got this beat.’”

Jason Tetro: “When healthcare leaders are meeting, I think that they’re going to listen to infection preventionists much more than they have in the past.”

Katherine Perez, PharmD: “For patients with COVID-19, I think the jury’s still out as to how we should be using antibiotics in those patients and what the risk of a secondary bacterial infection truly is. And that type of information has not been made available, at least not in huge amounts at this time.”

Jeffrey Rose: “I think the desire to break apart some of the functionality of the hospital and spread it out into other facilities-like oncology centers or ambulatory surgery centers-to reduce the large population at one building, is going to continue to grow. And in addition, if you design them correctly, you can use those facilities for surge capacity.”

Charles Gerba, PhD: Environmental services plays a crucial-and often unsung-role in infection prevention. “Unfortunately, we don’t honor people enough for things they prevented or that never happened.”

Daniel F. Shay, Esq.: “COVID-19 is not the last infectious disease that we’re going to encounter…. I think that there are good reasons to use telemedicine to the extent that you can reduce the risk to healthcare practitioners, healthcare professionals, and also to other patients, and, frankly, the general populace.”

Yi Guo, PharmD: “I think one thing that we learned is to work closely with the infection control preventionists because when we discovered the patient has multidrug resistant bacteria, we want to make sure the appropriate isolation policy is in place.”

Brooke Decker, MD: "Keep in mind that right now you’re generating those stories that you’re going to be telling junior colleagues for decades to come."

"We had to everyday kind of make some changes. Every morning there were huddles and we tried to figure it out."

Mary Jean Ricci, MSN, RN-BC: "Now we’re looking at [infection prevention] from a global perspective. Every patient needs to be educated because this is a novel virus and it is unknown."

Nicole York: "The dying process can take a long time, but I was with her while she was still alert. And I called up her family so that they could talk to her on the phone. But that’s all she got was just to talk to them on the phone."

Kalia Murray, EMT: "We are the first ones to arrive on a scene, often having no idea what we're walking into."

As we emerge from the COVID-19 crisis, it’s very important for infection control professionals to think, “How do we take this crisis and use it as a lever to cause the change that we care about so much?”

"We have to be comfortable with the fact that we have to reuse PPE for multiple patients. But one of the things they have to remember is those multiple patients all have the same illness. So, it’s not like we’re going to transfer multi-drug resistant organism to the next patient. Because we try not to use the same PPE for those situations."

Christina Tan, MD, MPH, state epidemiologist and assistant commissioner with the New Jersey Department of Health, discusses the current coronavirus outbreak and how infection prevention efforts can help curb its spread.

Exploring the importance of disinfecting non-critical and environmental surfaces.

This webinar will explain the imperatives for infection preventionists, environmental services professionals, and other healthcare stakeholders.

The BETR-D Study: The first and only randomized clinical trial on UVC Disinfection

The infection prevention and healthcare epidemiology community has continued to sound the alarm about outbreaks of CRE infections related to therapeutic gastrointestinal endoscopy cases in which contaminated and improperly reprocessed duodenoscopes and echoendoscopes were used during clinical procedures.

An increase in prevalence in healthcare settings across the continuum of care over several decades has resulted in MRSA and other multidrug-resistant organisms (MDROs) being given priority as targets of reduction efforts by several regulatory and advisory bodies. These include the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA) and the Centers for Disease Control and Prevention (CDC).

An increase in prevalence in healthcare settings across the continuum of care over several decades has resulted in MRSA and other multidrug-resistant organisms (MDROs) being given priority as targets of reduction efforts by several regulatory and advisory bodies. These include the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA) and the Centers for Disease Control and Prevention (CDC).

How over-the-head isolation gowns increase staff and visitor safety.

This Guidebook provides a comprehensive look at hand hygiene compliance monitoring, specifically electronic systems and how technology can drive improved performance.